Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1 - Wikidata - awgldk - TriplyDB

Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1

Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1

http://www.wikidata.org/entity/Q27662167

about

Glycan masking of Plasmodium vivax Duffy Binding Protein for probing protein binding function and vaccine development HIV-1 neutralizing antibodies: understanding nature's pathways HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design Shaping T cell - B cell collaboration in the response to human immunodeficiency virus type 1 envelope glycoprotein gp120 by peptide priming Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 Crystal Structure of Human Antibody 2909 Reveals Conserved Features of Quaternary Structure-Specific Antibodies That Potently Neutralize HIV-1 Crystal Structure of the HIV-2 Neutralizing Fab Fragment 7C8 with High Specificity to the V3 Region of gp125 Structural Analysis of Human and Macaque mAbs 2909 and 2.5B: Implications for the Configuration of the Quaternary Neutralizing Epitope of HIV-1 gp120 Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing Cross-neutralization of influenza A viruses mediated by a single antibody loop Structure-Based Design of a Protein Immunogen that Displays an HIV-1 gp41 Neutralizing Epitope Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2 Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16 The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies Functional Implications of the Binding Mode of a Human Conformation-Dependent V2 Monoclonal Antibody against HIV Recent Progress toward Engineering HIV-1-Specific Neutralizing Monoclonal Antibodies Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from India Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies A directed molecular evolution approach to improved immunogenicity of the HIV-1 envelope glycoprotein Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies.Recent advances on the use of structural biology for the design of novel envelope immunogens of HIV-1 H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans.Closing the door to human immunodeficiency virus.Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth.Antibodies VRC01 and 10E8 neutralize HIV-1 with high breadth and potency even with Ig-framework regions substantially reverted to germline.Immunotypes of a quaternary site of HIV-1 vulnerability and their recognition by antibodies Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C.Human peripheral blood antibodies with long HCDR3s are established primarily at original recombination using a limited subset of germline genes.B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function.Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41.Induction of immunity to human immunodeficiency virus type-1 by vaccination.Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo.N332-Directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of function.Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systems Neutralizing antibody responses in macaques induced by human immunodeficiency virus type 1 monovalent or trivalent envelope glycoproteins.

P2860

Q21558777-38CD9DD1-0BE8-4B8D-9B90-2920A60EF41F Q27000480-EE8B4018-65C9-45C1-87B5-6D445710E253 Q27022055-E9A3A21C-F78E-4329-8720-3989B96BC9B2 Q27316280-E4B78C3A-3523-4C5D-905E-1B375028D7E9 Q27644478-724E6715-3578-45DD-A3F1-FFFD8A9B0BC8 Q27644501-6FD14582-E86D-46B3-A9A0-B0D6EFD5319E Q27644634-26389C43-2648-4224-926B-6FD7CD4FC867 Q27663293-8477BBB6-1793-4F12-ADB4-E9C96B9FF19F Q27666407-5F8847AB-A4E5-49F6-88FB-F53B9F119475 Q27667679-6CACFC78-931B-446F-99CE-F2B01DD4D294 Q27667819-0B89B563-72BB-4A83-8A29-377B032D1937 Q27671696-7BC7A827-DB86-4F17-B5C6-F2BC3E61B803 Q27673206-D2A11AE4-E677-4284-8A75-11CC01C730A7 Q27675260-DDD051FC-E6EC-4DB3-944B-48FA7939C549 Q27675879-40FDD69E-F998-46B3-AC6B-110EF12D0311 Q27678312-EAAAEB40-42D8-4567-BDCD-3276C194950E Q27680688-1F964202-8BE9-4CEA-B053-8C1372B9E99F Q27681527-3B22A03F-DA06-441B-A502-C6B3F33EA89F Q28068946-FBC38B14-8DF9-4787-AA36-1E64588305E6 Q28483205-201D9826-C417-4B80-97BE-F2F9A8E60F97 Q28602877-4582505B-C160-4A32-BDA4-A984400C7D1D Q28743092-921BBA92-1FF9-46CA-8C99-227EB44D3EE4 Q30352300-ED531838-FD3F-4D01-8D3B-02751DC41199 Q30353580-D9DEAF43-BA50-4974-9609-B10C1D82DBAE Q30406365-7F8EFDF7-0C41-4D91-919E-88E10CD83C5B Q30428089-4AE2DE3F-B6EC-4ECC-A5CC-EB7FDED12784 Q30657338-0A343E60-9DBE-4F05-A839-65405F7D2550 Q34075820-87DD3868-07FB-4C48-B318-C9617EE5D12F Q34164923-D654295B-C9B5-4ECF-9C4B-FD81F54CEEAB Q34206171-61C85FD3-5DC1-4CE3-A112-A974E0F8DC5F Q34270980-80AB479A-DCC2-4F81-8B71-46BB3F7911CA Q34273373-F27E58F0-E27C-4236-B124-E831102AB1E0 Q34350894-A9AF0502-5337-4A70-A67D-95B74F66C6E1 Q34412302-145F2C66-C0C5-4D53-90D5-D1B43A04B250 Q34540645-0E3B30E9-1F1E-405C-B7F6-38A68E5EFC96 Q34555891-FB594BEE-9E75-48E7-BD20-6A3956E9CC32 Q34593860-745B8361-502B-4410-A539-171B0888FDB1 Q34594978-7F60E464-F2F2-4577-8276-ADCCBDD592B0 Q34637663-37C07A03-BF4B-4D63-8F15-CBBC35D143AB Q34637968-004040A6-09C0-40CC-A3B6-5EEB8CFB7417

P2860

Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1

http://www.wikidata.org/entity/Q27662167

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Crystal Structure of PG16 and ...... t Effectively Neutralize HIV-1

@ast

Crystal Structure of PG16 and ...... t Effectively Neutralize HIV-1

@en

Crystal Structure of PG16 and ...... t Effectively Neutralize HIV-1

@nl

type

label

Crystal Structure of PG16 and ...... t Effectively Neutralize HIV-1

@ast

Crystal Structure of PG16 and ...... t Effectively Neutralize HIV-1

@en

Crystal Structure of PG16 and ...... t Effectively Neutralize HIV-1

@nl

prefLabel

Crystal Structure of PG16 and ...... t Effectively Neutralize HIV-1

@ast

Crystal Structure of PG16 and ...... t Effectively Neutralize HIV-1

@en

Crystal Structure of PG16 and ...... t Effectively Neutralize HIV-1

@nl

P1433

Q27662167-7F0146DC-0B88-400F-95A4-68B0473E9272

P1476

Q27662167-60E4AA99-2BAF-401F-B2C6-F966F33F9A75

P2093

Q27662167-4305371D-B71A-4912-B454-D797079B0006

Q27662167-433495D8-B67F-4FEA-830C-3FE7D52FFFA0

Q27662167-45C749F5-F889-494C-A89F-7A26579418AD

Q27662167-6AE1AC7D-09C0-4CA3-BB0E-E447E0AAC6E0

Q27662167-7FF54A53-22CE-41B8-AFE6-C51DF27A3B0B

Q27662167-DB71C55C-1793-425A-9D0B-475C5876DDD8

Q27662167-DC373A1F-93C2-421F-BF83-831BE91D2B41

Q27662167-E8CCF495-6B1A-4FB8-9676-978173547597

Q27662167-F62A94AC-93B6-48C8-8908-33406DF133D3

P2860

Q27662167-073EDED1-6DD6-4F71-B389-F4042FDD3515

Q27662167-0A8B6E66-D75B-42E5-96B3-22A374E1D0AC

Q27662167-10C3C20A-3788-4C22-8739-B6CC5D3018C8

Q27662167-1596FA33-7250-42D3-AF7E-5A6261528A15

Q27662167-18788A1D-9D97-443B-B969-DF2D58A0EC9F

Q27662167-23CA3D76-880B-4C47-845C-AD967916D0F7

Q27662167-270CB1F5-198E-4465-8007-624CED86D49C

Q27662167-290D1006-CEFB-4DE6-AAD3-4D378C504971

Q27662167-2C7280C1-14F6-46A4-B7FC-D5D9E02B8CDB

Q27662167-2DA48EAC-E985-41FC-B7CF-2F23DDF55847

P304

Q27662167-E0BD76CD-578E-4C53-BF60-E7B9F4CB744F

P31

Q27662167-DB6F7F8C-D1D5-4C59-AB86-4BB0DA0938F3

P3181

Q27662167-C4ED45D8-AF16-4C54-8D32-3DFAF3602212

P356

Q27662167-C088DDE2-0209-4201-9330-23F4E29624A2

P433

Q27662167-94A3BCF8-58C7-4F90-BC63-1963FBDE9D6A

P478

Q27662167-3120D74C-92E7-41AC-9B79-6E60825C71CC

P50

Q27662167-5EAABE55-46EE-41B2-97E5-2A993D1AB4CB

Q27662167-C076A803-A550-457D-B34E-EA42BB5F4CE1

P577

Q27662167-EBF788FF-3095-4954-A921-568F37EFC1CA

P698

Q27662167-032ACF40-0589-459C-8882-24A0B7086CEC

P921

Q27662167-11336DCF-95DA-431B-81CE-EE7772FFDEC8

Q27662167-90A5765F-68EC-42A6-822B-B02784112817

P932

Q27662167-BFDA2B28-334E-4509-A30A-F81E3D40687A

P3181

P356

P1433

Journal of Virology

P1476

Crystal structure of PG16 and ...... t effectively neutralize HIV-1

@en

P2093

Anita Changela

http://www.w3.org/2001/XMLSchema#string

Jiang Zhu

http://www.w3.org/2001/XMLSchema#string

John R Mascola

http://www.w3.org/2001/XMLSchema#string

Marie Pancera

http://www.w3.org/2001/XMLSchema#string

Peter D Kwong

http://www.w3.org/2001/XMLSchema#string

Sanjay Phogat

http://www.w3.org/2001/XMLSchema#string

Stephen D Schmidt

http://www.w3.org/2001/XMLSchema#string

Xueling Wu

http://www.w3.org/2001/XMLSchema#string

Yongping Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of the calcium-stabilized human factor IX Gla domain bound to a conformation-specific anti-factor IX antibody

TM-align: a protein structure alignment algorithm based on the TM-score

Crystal structures of two human pyrophosphorylase isoforms in complexes with UDPGlc(Gal)NAc: role of the alternatively spliced insert in the enzyme oligomeric assembly and active site architecture.

Antibody vs. HIV in a clash of evolutionary titans

Therapeutic antibodies, vaccines and antibodyomes

MolProbity: all-atom structure validation for macromolecular crystallography

Structural definition of a conserved neutralization epitope on HIV-1 gp120

Improved methods for building protein models in electron density maps and the location of errors in these models

Crystal structure of uridine-diphospho-N-acetylglucosamine pyrophosphorylase from Candida albicans and catalytic reaction mechanism

Evolution of Enzymatic Activities in the Enolase Superfamily: Stereochemically Distinct Mechanisms in Two Families of cis , cis -Muconate Lactonizing Enzymes † ‡

P304

8098-8110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

415011

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.00966-10

http://www.w3.org/2001/XMLSchema#string

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

Jason S McLellan

P577

2010-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20538861

http://www.w3.org/2001/XMLSchema#string

P921

crystal structure

P932

2916520

http://www.w3.org/2001/XMLSchema#string